127 related articles for article (PubMed ID: 12182466)
1. CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely.
Corbascio M; Ekstrand H; Osterholm C; Qi Z; Simanaitis M; Larsen CP; Pearson TC; Riesbeck K; Ekberg H
Transpl Immunol; 2002 Jun; 10(1):55-61. PubMed ID: 12182466
[TBL] [Abstract][Full Text] [Related]
2. CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice.
Malm H; Corbascio M; Osterholm C; Cowan S; Larsen CP; Pearson TC; Ekberg H
Transplantation; 2002 Jan; 73(2):293-7. PubMed ID: 11821746
[TBL] [Abstract][Full Text] [Related]
3. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
4. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
Lin H; Bolling SF; Linsley PS; Wei RQ; Gordon D; Thompson CB; Turka LA
J Exp Med; 1993 Nov; 178(5):1801-6. PubMed ID: 8228826
[TBL] [Abstract][Full Text] [Related]
5. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection.
Miwa S; Isobe M; Suzuki J; Makuuchi M; Miyasaka M; Yamazaki S; Kawasaki S
Surgery; 1997 Jun; 121(6):681-9. PubMed ID: 9186469
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
[TBL] [Abstract][Full Text] [Related]
8. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
[TBL] [Abstract][Full Text] [Related]
9. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
[TBL] [Abstract][Full Text] [Related]
10. Blockade of adhesion molecule lymphocyte function-associated antigen-1 improves long-term heart allograft survival in mixed chimeras.
Pilat N; Sabler P; Klaus C; Mahr B; Unger L; Hock K; Wiletel M; Schwarz C; Kristo I; Regele H; Wekerle T
J Heart Lung Transplant; 2018 Sep; 37(9):1119-1130. PubMed ID: 29699851
[TBL] [Abstract][Full Text] [Related]
11. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
[TBL] [Abstract][Full Text] [Related]
12. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
[TBL] [Abstract][Full Text] [Related]
13. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
[TBL] [Abstract][Full Text] [Related]
15. IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.
Sucher R; Fischler K; Oberhuber R; Kronberger I; Margreiter C; Ollinger R; Schneeberger S; Fuchs D; Werner ER; Watschinger K; Zelger B; Tellides G; Pilat N; Pratschke J; Margreiter R; Wekerle T; Brandacher G
J Immunol; 2012 Jan; 188(1):37-46. PubMed ID: 22131334
[TBL] [Abstract][Full Text] [Related]
16. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig.
Guillot C; Ménoret S; Guillonneau C; Braudeau C; Castro MG; Lowenstein P; Anegon I
Blood; 2003 Apr; 101(8):3325-33. PubMed ID: 12515725
[TBL] [Abstract][Full Text] [Related]
17. Lack of cognate help by CD4+ T cells and anergy of CD8+ T cells are the principal mechanisms for anti-leukocyte function-associated antigen-1/intercellular adhesion molecule-1-induced cardiac allograft tolerance.
Bashuda H; Seino K; Ra C; Yagita H; Okumura K
Transplantation; 1997 Jan; 63(1):113-8. PubMed ID: 9000671
[TBL] [Abstract][Full Text] [Related]
18. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival.
Bolling SF; Lin H; Wei RQ; Linsley P; Turka LA
J Surg Res; 1994 Jul; 57(1):60-4. PubMed ID: 8041150
[TBL] [Abstract][Full Text] [Related]
19. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
[TBL] [Abstract][Full Text] [Related]
20. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo.
Yuan X; Salama AD; Dong V; Schmitt I; Najafian N; Chandraker A; Akiba H; Yagita H; Sayegh MH
J Immunol; 2003 Mar; 170(6):2949-55. PubMed ID: 12626546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
